UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Chemotherapy without irradiation : A novel approach for newly diagnosed CNS germ cell tumors : results of an international cooperative trial

Journal of clinical oncology, 1996-11, Vol.14 (11), p.2908-2915

1996

Volltextzugriff (PDF)

High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity

Journal of clinical oncology, 1996-04, Vol.14 (4), p.1098-1105

1996

Volltextzugriff (PDF)

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

Journal of clinical oncology, 1992-01, Vol.10 (1), p.5-15

1992

Volltextzugriff (PDF)

High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors

Journal of clinical oncology, 1997-07, Vol.15 (7), p.2546-2552

1997

Volltextzugriff (PDF)

Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival

Journal of clinical oncology, 1997-07, Vol.15 (7), p.2559-2563

1997

Volltextzugriff (PDF)

Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer

Journal of clinical oncology, 1993-04, Vol.11 (4), p.607-615

1993

Volltextzugriff (PDF)

Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center

Journal of clinical oncology, 1996-02, Vol.14 (2), p.454-460

1996

Volltextzugriff (PDF)

Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up

Journal of clinical oncology, 1993-07, Vol.11 (7), p.1368-1375

1993

Volltextzugriff (PDF)

Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro

Journal of clinical oncology, 1995-08, Vol.13 (8), p.1950-1957

1995

Volltextzugriff (PDF)

Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms

Cancer, 1994-08, Vol.74 (3), p.907-915

1994

Volltextzugriff (PDF)

Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients

Journal of clinical oncology, 1994-01, Vol.12 (1), p.120-126

1994

Volltextzugriff (PDF)

Phase II Trial of High-Dose Carboplatin and Etoposide With Autologous Bone Marrow Transplantation in First-Line Therapy for Patients With Poor-Risk Germ Cell Tumors

JNCI : Journal of the National Cancer Institute, 1993-11, Vol.85 (22), p.1828-1835

1993

Volltextzugriff (PDF)

Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin

Journal of clinical oncology, 1997-07, Vol.15 (7), p.2553-2558

1997

Volltextzugriff (PDF)

Expression of Basic Fibroblast Growth Factor in Primary Human Renal Tumors: Correlation With Poor Survival

JNCI : Journal of the National Cancer Institute, 1993-10, Vol.85 (19), p.1597-1599

1993

Volltextzugriff (PDF)

Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors

Journal of clinical oncology, 1995-11, Vol.13 (11), p.2700-2704

1995

Volltextzugriff (PDF)

Metastatic germ cell tumors: modeling for response to chemotherapy

Journal of clinical oncology, 1998-02, Vol.16 (2), p.707-715

1998

Volltextzugriff (PDF)

Distribution of Retroperitoneal Metastases After Chemotherapy in Patients With Nonseminomatous Germ Cell Tumors

The Journal of urology, 1992-12, Vol.148 (6), p.1812-1815

1992

Volltextzugriff (PDF)

Differentiated thyroid cancer : Determinants of disease progression in patients <21 years of age at diagnosis : A report from the surgical discipline committee of the children's cancer group

Annals of surgery, 1998-04, Vol.227 (4), p.533-541

1998

Volltextzugriff (PDF)

Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancer

Journal of clinical oncology, 1995-09, Vol.13 (9), p.2214-2222

1995

Volltextzugriff (PDF)

Phase iii randomized trial of interleukin‐2 with or without lymphokine‐activated killer cells in the treatment of patients with advanced renal cell carcinoma

Cancer, 1995-09, Vol.76 (5), p.824-832

1995

Volltextzugriff (PDF)

Prognostic factors in differentiated carcinoma of the thyroid gland

The American journal of surgery, 1992-12, Vol.164 (6), p.658-661

1992

Volltextzugriff (PDF)

Reactivity of glutaredoxins 1, 2, and 3 from Escherichia coli shows that glutaredoxin 2 is the primary hydrogen donor to ArsC-catalyzed arsenate reduction

The Journal of biological chemistry, 1999-12, Vol.274 (51), p.36039-36042

1999

Volltextzugriff (PDF)

Tamoxifen Use in Breast Cancer Patients Who Subsequently Develop Corpus Cancer Is Not Associated with a Higher Incidence of Adverse Histologic Features

Gynecologic oncology, 1994-11, Vol.55 (2), p.164-168

1994

Volltextzugriff (PDF)

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

Journal of clinical oncology, 1993-04, Vol.11 (4), p.598-606

1993

Volltextzugriff (PDF)

Cytoreductive Surgery in Ovarian Carcinoma Patients with a Documented Previously Complete Surgical Response

Gynecologic oncology, 1995-04, Vol.57 (1), p.61-65

1995

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(45)
Tagungsberichte
(3)

Sprache

Englisch
(48)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(39)
Science & Technology
(39)
Humans
(37)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Oncology
(28)
Adult
(27)
Male
(27)
Middle Aged
(21)
Antineoplastic Agents
(19)
Female
(19)
Pharmacology. Drug Treatments
(19)
Adolescent
(17)
Chemotherapy
(17)
Aged
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(15)
Survival Analysis
(14)
Tumors
(12)
Cisplatin - Administration & Dosage
(11)
Etoposide - Administration & Dosage
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chemotherapy without irradiation : A novel approach for newly diagnosed CNS germ cell tumors : results of an international cooperative trial

High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors

Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival

Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer

Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center

Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up

Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro

Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms

Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients

Phase II Trial of High-Dose Carboplatin and Etoposide With Autologous Bone Marrow Transplantation in First-Line Therapy for Patients With Poor-Risk Germ Cell Tumors

Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin

Expression of Basic Fibroblast Growth Factor in Primary Human Renal Tumors: Correlation With Poor Survival

Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors

Metastatic germ cell tumors: modeling for response to chemotherapy

Distribution of Retroperitoneal Metastases After Chemotherapy in Patients With Nonseminomatous Germ Cell Tumors

Differentiated thyroid cancer : Determinants of disease progression in patients <21 years of age at diagnosis : A report from the surgical discipline committee of the children's cancer group

Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancer

Phase iii randomized trial of interleukin‐2 with or without lymphokine‐activated killer cells in the treatment of patients with advanced renal cell carcinoma

Prognostic factors in differentiated carcinoma of the thyroid gland

Reactivity of glutaredoxins 1, 2, and 3 from Escherichia coli shows that glutaredoxin 2 is the primary hydrogen donor to ArsC-catalyzed arsenate reduction

Tamoxifen Use in Breast Cancer Patients Who Subsequently Develop Corpus Cancer Is Not Associated with a Higher Incidence of Adverse Histologic Features

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

Cytoreductive Surgery in Ovarian Carcinoma Patients with a Documented Previously Complete Surgical Response

Suchergebnisse filtern